BEFORE CARE / HEALTH BRIEF
A fast checkout is not the same as a medical review. Before the visit, list your own and your family’s past illnesses, your medicines, any pregnancy plans, and any surgery coming up.
COMMON EFFECTS
For every 100 participants in Zepbound weight trials, roughly 25 to 29 on tirzepatide reported nausea, compared with 8 on a dummy shot.
Diarrhea, vomiting, and constipation were also common side effects in those trials.
Ask who handles a problem, how fast they respond, and where the plan is written.
LABEL FILE
Both tirzepatide labels carried the FDA’s strongest warning about thyroid tumors seen in rats, and whether tirzepatide causes these tumors in people was not known.
The label barred tirzepatide for anyone who has had medullary thyroid cancer, a rare thyroid cancer, or whose relatives have had it.
It was likewise barred for people with MEN 2, an uncommon condition passed down in families, and for people with a serious allergy to tirzepatide.
The Zepbound label said oral birth control could work less well for 4 weeks after starting and for 4 weeks after each dose increase.
This is the label’s instruction, not a dosing plan from this guide.
The tirzepatide labels warned that food left in the stomach could be breathed into the lungs when a patient is put fully to sleep or deeply sedated.
Tell the team about any operation or procedure where you will be put to sleep or heavily sedated.
The labels do not settle when to stop. That decision belongs with the care team.
URGENT HELP
A life-threatening allergy may begin in seconds or minutes; treat that as an emergency.
Emergency signs include hard breathing, face or tongue swelling, fainting, or unconsciousness.
The label also reported rare serious pancreas inflammation and serious allergic reactions.